Guided by compassion, grounded in clinical expertise.
We provide personalized psychiatric care and holistic mental health support
- virtually, with integrity and intention
Virtual Appointments Only
Currently offering telehealth appointments to all New Jersey residents.
In-Person visits available in Forked River, NJ and Edison, NJ for certain circumstances, consistent with standards of care and regulatory requirements
New Jersey regulations (N.J.A.C. § 13:35‑2C.6) require an initial in‑person examination before a provider may prescribe Schedule II controlled substances via telehealth, such as stimulants for ADHD, and a subsequent in‑person visit at least every three months while the patient is being prescribed these medications.
In‑Person appointments are mandatory per these New Jersey regulations when initiating and maintaining Schedule II controlled medication prescriptions.
Accepting telehealth patients in all of New York state soon!
Opening Summer of 2026
In-Person visits available in New York, NY for certain circumstances, consistent with standards of care and regulatory requirements
New York regulations (10 NYCRR § 80.63) require an in-person medical evaluation before a provider may prescribe a controlled substance via telehealth.
An exception may apply when the provider has reviewed records documenting an in-person evaluation by a referring or consulting healthcare professional within the previous 12 months for the condition being treated.
Patients seeking treatment that may involve controlled medications, including stimulant medications for ADHD, may be required to complete an in-person evaluation or provide appropriate documentation from a referring healthcare provider before a controlled medication can be prescribed.
In-person appointments may be required to comply with applicable New York State and federal regulations governing controlled substance prescribing.
Why should you choose us?
We're client centered and compassionate
We combine clinical expertise with a holistic approach, offering personalized care that supports your whole well-being—mind, body, and spirit.
Depression
PTSD
ADHD
Impulse Control Disorders
Anxiety
Bipolar Disorders
OCD
and more!
Disclaimer
This practice does not prescribe benzodiazepines due to the Boxed warnings and risks outlined by the FDA including the "risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions".
Understanding Benzodiazepine Use and Safer Long-Term Strategies
Benzodiazepines (such as Xanax, Ativan, Klonopin, and Valium) are a class of medications primarily indicated for short-term use in the treatment of acute anxiety or panic symptoms. Current clinical guidelines recommend their use only during the initial phase of treatment—while a safer, long-term strategy is being established, such as starting an SSRI or SNRI and engaging in evidence-based psychotherapy (e.g., CBT).
Long-term benzodiazepine use is associated with a range of concerning outcomes, including:
Rebound anxiety and worsening of baseline symptoms
Sleep disturbances and chronic insomnia
Physical tolerance and psychological dependence
Increased risk of cognitive impairment, including early-onset dementia and Alzheimer’s disease (per emerging longitudinal research)
If you are currently taking a benzodiazepine and would like to come off this medication, we can help. Our team can help design a personalized tapering plan tailored to your needs. This includes close monitoring, adjunctive medications when appropriate to minimize withdrawal risks (such as seizures), and the integration of treatments to support anxiety management and overall wellness.
Additional Disclaimer:
New Jersey regulations (N.J.A.C. § 13:35‑2C.6) require an initial in‑person examination before a provider may prescribe Schedule II controlled substances via telehealth, such as stimulants for ADHD, and a subsequent in‑person visit at least every three months while the patient is being prescribed these medications.
In‑Person appointments are mandatory per these New Jersey regulations when initiating and maintaining Schedule II controlled medication prescriptions.
New York regulations (10 NYCRR § 80.63) require an in-person medical evaluation before a provider may prescribe a controlled substance via telehealth.